Advances in the treatment of melanoma

Clin Med (Lond). 2012 Apr;12(2):168-71. doi: 10.7861/clinmedicine.12-2-168.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • Autoimmunity / drug effects*
  • Disease Management*
  • Humans
  • Immunologic Factors / therapeutic use
  • Indoles / therapeutic use*
  • Ipilimumab
  • Melanoma / immunology
  • Melanoma / pathology
  • Melanoma / therapy*
  • Skin Neoplasms / immunology
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy
  • Sulfonamides / therapeutic use*
  • Therapies, Investigational
  • Vemurafenib

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Immunologic Factors
  • Indoles
  • Ipilimumab
  • Sulfonamides
  • Vemurafenib